Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.43 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2220355 | 1.00 | USP2 (0.56) | USP2SMN1; SMN2MAPK1HPGDEPHX2 | |
| SCHEMBL17297711 | 0.98 | USP2 (0.55) | USP2SMN1; SMN2MAPK1HPGDEPHX2 | |
| SCHEMBL1225127 | 0.98 | USP2 (0.58) | USP2SMN1; SMN2MAPK1HPGDEPHX2 | |
| SCHEMBL12005408 | 0.98 | USP2 (0.58) | USP2SMN1; SMN2MAPK1HPGDEPHX2 | |
| SCHEMBL587550 | 0.98 | USP2 (0.58) | USP2SMN1; SMN2MAPK1HPGDEPHX2 | |
| SCHEMBL8286 | 0.98 | USP2 (0.58) | USP2SMN1; SMN2MAPK1HPGDEPHX2 | |
| Ammonia Solution, Strong SCHEMBL18035416 | 0.96 | USP2 (0.56) | USP2SMN1; SMN2MAPK1HPGDEPHX2 | |
| SCHEMBL14653343 | 0.96 | USP2 (0.56) | USP2SMN1; SMN2MAPK1HPGDEPHX2 | |
| Hydrochloric Acid SCHEMBL1904026 | 0.96 | USP2 (0.56) | USP2SMN1; SMN2MAPK1HPGDEPHX2 | |
| Hydrochloric Acid SCHEMBL4141237 | 0.96 | USP2 (0.56) | USP2SMN1; SMN2MAPK1HPGDEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110632010-B | Glyphosate detection method based on catalytic sensing | 膳安(厦门)智能科技有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-113533233-A | Acetylcholinesterase catalytic spectrum sensing detection system and detection method | 华侨大学 | 2021-10-22 | — | — | CN | claimed |
| CN-110632010-A | Glyphosate detection method based on catalytic sensing | 膳安(厦门)智能科技有限公司 | 2019-12-31 | — | — | CN | claimed |
| US-12637398-B2 | Radiohalogen prosthetic moieties and radiolabeled biomolecules | DUKE UNIVERSITY (US) | 2026-05-26 | — | — | US | disclosed |
| CN-122094950-A | Ligand compound with quinoline structure, and radioactive or non-radioactive marker and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260109732-A1 | LIPID AMINES | MODERNATX INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20250235531-A1 | MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS | MODERNATX, INC. (US) | 2025-07-24 | — | — | US | disclosed |
| US-20250222143-A1 | TARGETED RADIOTHERANOSTICS BASED ON POLYAZAMACROCYCLIC, MIXED-DONOR SCAFFOLDS LINKED TO A TARGETING VECTOR | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2025-07-10 | — | — | US | disclosed |
| CN-113453720-B | Dual ligand drug conjugate and uses thereof | 同宜医药（苏州）有限公司 | 2025-05-06 | — | — | CN | disclosed |
| WO-2025087229-A1 | LIGAND COMPOUND OF QUINOLINE STRUCTURE, RADIOACTIVE OR NON-RADIOACTIVE MARKER, AND USE | 四川科伦博泰生物医药股份有限公司 | 2025-05-01 | — | — | WO | disclosed |
| WO-2025087466-A2 | LIGAND COMPOUND OF QUINOLINE STRUCTURE, AND RADIOACTIVE OR NON-RADIOACTIVE MARKER THEREOF AND USE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2025-05-01 | — | — | WO | disclosed |
| US-20090246130-A1 | Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules | IMMUNOMEDICS, INC. (US) | 2009-10-01 | — | — | US | disclosed |
| US-20090155166-A1 | Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules | IMMUNOMEDICS, INC. (US) | 2009-06-18 | — | — | US | disclosed |
| US-20080167443-A1 | Novel chelating agents and highly luminescent and stable chelates and their use | WALLAC OY (FI) | 2008-07-10 | — | — | US | disclosed |
| US-20080167443-A1 | Novel chelating agents and highly luminescent and stable chelates and their use | WALLAC OY (FI) | 2008-07-10 | — | — | US | disclosed |
| US-20080167443-A1 | Novel chelating agents and highly luminescent and stable chelates and their use | WALLAC OY (FI) | 2008-07-10 | — | — | US | disclosed |
| EP-1658282-A1 | NOVEL CHELATING AGENTS AND CHELATES AND THEIR USE | WALLAC OY (FI) | 2006-05-24 | — | — | EP | disclosed |
| US-20050181393-A1 | Novel chelating agents and highly luminescent and stable chelates and their use | WALLAC OY (FI) | 2005-08-18 | — | — | US | disclosed |
| US-20050084451-A1 | Novel chelating agents and chelates and their use | WALLAC OY | 2005-04-21 | — | — | US | disclosed |
| WO-2005021538-A1 | NOVEL CHELATING AGENTS AND CHELATES AND THEIR USE | WALLAC OY (FI) | 2005-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250235531-A1 | MUCOSAL ADMINISTRATION METHODS AND FORMULATIONS | MUC1, RNMT, FABP2 | USP2 1671/4885SMN1; SMN2 931/4885MAPK1 4617/4885 |
| US-20250222143-A1 | TARGETED RADIOTHERANOSTICS BASED ON POLYAZAMACROCYCLIC, MIXED-DONOR SCAFFOLDS LINKED TO A TARGETING VECTOR | PAICS, RABGGTB, PARP1 | USP2 3438/4885SMN1; SMN2 3520/4885MAPK1 4343/4885 |
| US-20090246130-A1 | Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules | F13B, TFRC, F13A1 | USP2 3132/4885SMN1; SMN2 2184/4885MAPK1 3977/4885 |
| US-20050084451-A1 | Novel chelating agents and chelates and their use | DNPEP, CNBP, CLTA | USP2 2826/4885SMN1; SMN2 3630/4885MAPK1 4254/4885 |
| US-12637398-B2 | Radiohalogen prosthetic moieties and radiolabeled biomolecules | CD47, KLK3, SHBG | USP2 3562/4885SMN1; SMN2 4594/4885MAPK1 2709/4885 |
| US-20080167443-A1 | Novel chelating agents and highly luminescent and stable chelates and their use | CLTA, CLTC, FOLH1 | USP2 2887/4885SMN1; SMN2 3423/4885MAPK1 4466/4885 |
| US-20090155166-A1 | Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules | S100A8, TFRC, F13A1 | USP2 3204/4885SMN1; SMN2 3021/4885MAPK1 4510/4885 |
| US-20260109732-A1 | LIPID AMINES | LDLR, NPC1, PHOSPHO1 | USP2 3959/4885SMN1; SMN2 1002/4885MAPK1 2720/4885 |
| US-20050181393-A1 | Novel chelating agents and highly luminescent and stable chelates and their use | CLTA, CLTC, FOLH1 | USP2 2887/4885SMN1; SMN2 3423/4885MAPK1 4466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.